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An emerging body of literature recognizes the relationship 
between stress and inflammation. The kynurenine pathway is 
particularly relevant because it accounts for the majority of 
tryptophan’s metabolism [1]. Activation of the kynurenine 
pathway depletes the tryptophan pool for serotonin, and has 
been associated with the emergence of depressive-like 
symptoms and “sickness behaviour” (anhedonia, anxiety, and 
sleep disturbances) in animals [1]. The first and rate limiting 
step of the kynurenine pathway converts tryptophan to 
kynurenine and can be catalyzed by tryptophan 2,3-
dioxygenase (TDO), which operates under basal conditions, or 
by indoleamine 2,3-dioxygenase 1 (IDO1), which 
predominates under inflammatory states [2]. Indeed, previous 
research has shown that IDO1 can be induced by cytokines, 
such as tumor necrosis factor alpha (TNFα) [1,2]. Recent data 
from our lab indicates that TNFα protein is increased in the 
amygdala 4 h after exposure to an acute stressor. Hence, this 
investigation attempted to determine the effects of acute stress 
on mRNA levels of enzymes regulating the kynurenine 
pathway. 
METHODS 
Adult, male, Sprague Dawley rats (N=48) were subjected to 
120 minutes of restraint stress and rapidly decapitated 1 h, 2 h, 
4 h, 6 h, or 24 h later. Trunk blood was collected and analyzed 
for circulating corticosterone and TNFα levels. Brains were 
extracted and excised into amygdalae, hypothalami, prefrontal 
cortices, and hippocampi. RNA was isolated, followed by 
cDNA synthesis, and quantitative PCR (qPCR) to quantify 
mRNA levels of IDO1, TDO, kynurenine aminotransferase 1 
(KAT1), kynurenine 3-monooxygenase (KYNM), 
kynureninase (KYNU), and 3-hydroxyanthranilate 3,4-
dioxygenase. 
RESULTS 
Results indicated that plasma corticosterone levels were 
elevated 2 h after the acute stressor, while circulating levels of 
TNFα were increased at the 1 h and the 2 h post stress time 
points. Analysis of amygdalar qPCR data indicated an 
upregulation of IDO1 mRNA at the 1 h time point, and 
increased KYNM and KYNU mRNA at the 4 h time point. 
There were no amygdalar mRNA changes in the other genes. 
Regarding hypothalamic data, there was an increase in TDO 
mRNA at the 4 h time point and KYNU mRNA at the 1 h time 
point. These results are summarized in Figure 1. 
DISCUSSION AND CONCLUSIONS 
Increases in expression of kynurenine pathway enzymes in the 
amygdala occurred in a time dependent manner. Taken 
together, the data is concordant with previous reports, which 
indicate that IDO1 and TDO can be induced by TNFα and 
corticosterone, respectively [1,2]. The result of increased 
amygdalar KYNM and KYNU mRNA following acute stress 
represents a novel finding and suggests that stress shifts the 
kynurenine pathway towards neurotoxic metabolites, such as 
3-hyroxykynurenine and quinolinic acid, which may aggravate 
the symptoms of inflammation-induced depression. Follow up 
work on this study would investigate mRNA changes in other 
brain regions, such as the prefrontal cortex and the 
hippocampus. In addition, plasma and brain concentrations of 
tryptophan, kynurenine, kynurenic acid, and quinolinic acid 
would be determined to see if they are in accordance with the 
mRNA data. Ultimately, the present study highlights the 
kynurenine pathway as a potential therapeutic target for 
inflammation-induced depression.  
 
Figure 1. Enzymes and metabolites of the kynurenine 
pathway along with the results obtained in this experiment. 
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